Healthcare organizations often measure laboratories by cost, efficiency, and test volumes, overlooking their broader impact on patient care and health system performance.

In this episode, Tricia Ravalico, Director of Scientific Leadership, Core Diagnostics at Abbott, speaks with Khosrow Shotorbani, President and CEO, Clinical Lab 2.0, about redefining the value of diagnostics. Drawing on decades of leadership experience, Khosrow explains why laboratories should be viewed not as cost centers, but as strategic partners that improve clinical outcomes, reduce risk, and enhance healthcare efficiency.